Pharmaceutical Executive
If policy makers crafting a Medicare pharmacy benefit are worried about heavy prescription spending by seniors, they should take a closer look at medication use by the five million disabled beneficiaries in the program of 40 million patients.
If policy makers crafting a Medicare pharmacy benefit are worried about heavy prescription spending by seniors, they should take a closer look at medication use by the five million disabled beneficiaries in the program of 40 million patients. Medicare provides healthcare coverage for individuals under 65 who are totally and permanently disabled. Many qualify for Medicaid pharmacy benefits, but their low incomes make paying for prescription medicines particularly burdensome, according to a report on "Medicare's Disabled Beneficiaries: The Forgotten Population in the Debate Over Drug Benefits" from the Commonwealth Fund and the Henry J. Kaiser Family Foundation. That population fills more prescriptions and spends more on medicines each year than the elderly. (See "The Other Medicare Patients.")
The Other Medicare Patients
Moreover, the report points out, disabled Medicare beneficiaries use a different mix of pharmaceuticals than seniors do. Most notable is the heavy use of psychotherapeutics and analgesics -both low on the list of drugs commonly used by Medicare patients. (See "One Program, Two Lists.")
One Program, Two Lists
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.